je.st
news
Home
› Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia
Weill Cornell Medical College And Cellectis Announce Research Alliance Advancing Drug Discovery And The Translation Of Novel Immunotherapies In Leukemia
2015-06-03 05:49:21| drugdiscoveryonline Home Page
Regulatory News: Weill Cornell Medical College and Cellectis have entered into a strategic translational research alliance to accelerate the development of a targeted immunotherapy for patients with acute myelogenous leukemia (AML), a deadly blood cancer
Tags: in
research
college
medical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||